Join
Live feed
·
INSIDERFilingvia Quantisnow
Ionis Pharmaceuticals Inc. logo

Chief Executive Officer Monia Brett P converted options into 89,145 shares and sold $3,294,624 worth of shares (44,034 units at $74.82), increasing direct ownership by 25% to 224,683 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IONS (Ionis Pharmaceuticals Inc.) and more on Quantisnow.